Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3913-3921

  Netchine, Irène ^a,b,c   Azzi, Salah ^b,c   Houang, Muriel ^a,b   Seurin, Danielle ^b   Perin, Laurence ^a   Ricort, Jean Marc ^d   Daubas, Claudine ^b   Legay, Christine ^d   Mester, Jan ^b   Herich, Robert ^b   Godeau, François ^b   Le Bouc, Yves ^a,b,c  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Ecole Normale Superieure de Cachan   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BRAIN DEVELOPMENT; CASE REPORT; CATCH UP GROWTH; CELL PROLIFERATION; CHILD; CONSANGUINITY; FETUS DEVELOPMENT; GENE MUTATION; GROWTH; HORMONAL THERAPY; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNOASSAY; INTELLECTUAL IMPAIRMENT; INTRAUTERINE GROWTH RETARDATION; MALE; MICROCEPHALY; MISSENSE MUTATION; MITOGENICITY; NUCLEOTIDE SEQUENCE; PEDIGREE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMALL FOR DATE INFANT; SURFACE PLASMON RESONANCE;

EID: 70349898604     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0452     Document Type: Article

References (39)

1. Gicquel C, Le Bouc Y 2006 Hormonal regulation of fetal growth. Horm Res 65(Suppl 3):28-33
2. Wollmann HA 1998 Intrauterine growth restriction: definition and etiology. Horm Res 49(Suppl 2):1-6 (Pubitemid 128707153)
3. Randhawa R, Cohen P 2005 The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86:84-90 (Pubitemid 41412163)
4. Walenkamp MJ, Wit JM 2007 Genetic disorders in the GH IGF-I axis in mouse and man. Eur J Endocrinol 157(Suppl 1):S15-S26
5. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I, Le BoucY2005 Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 37:1003-1007
6. Netchine I, Rossignol S, Dufourg MN, Azzi S, Rousseau A, Perin L, Houang M, Steunou V, Esteva B, Thibaud N, Demay MC, Danton F, Petriczko E, Bertrand AM, Heinrichs C, Carel JC, Loeuille GA, Pinto G, Jacquemont ML, Gicquel C, Cabrol S, Le Bouc Y 2007 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 92:3148-3154 (Pubitemid 47236384)
7. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367 (Pubitemid 26360455)
8. Bonapace G, Concolino D, Formicola S, Strisciuglio P 2003 A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 40:913-917 (Pubitemid 38117542)
9. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM 2005 Homozygousandheterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 90:2855-2864 (Pubitemid 40686336)
10. Rosenfeld RG 2007 IGF-I therapy in growth disorders. Eur J Endocrinol 157(Suppl 1):S57-S60
11. Raynaud-Simon A, Perin L, Meaume S, Lesourd B, Moulias R, Postel- Vinay MC, Le Bouc Y 2002 IGF-I, IGF-I-binding proteins and GH-binding protein in malnourished elderly patients with inflammation receiving refeeding therapy. Eur J Endocrinol 146:657-665 (Pubitemid 34552499)
12. Rasmussen SK, Lautier C, Hansen L, Echwald SM, Hansen T, Ekstrøm CT, Urhammer SA, Borch-Johnsen K, Grigorescu F, Smith RJ, PedersenO2000 Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. J Clin Endocrinol Metab 85:1606-1610
13. Mahiou J, Abastado JP, Cabanie L, Godeau F 1998 Soluble FasR ligand-binding domain: high-yield production of active fusion and non-fusion recombinant proteins using the baculovirus/insect cell system. Biochem J 330:1051-1058 (Pubitemid 28112016)
14. Le Bouc Y, Dreyer D, Jaeger F, Binoux M, Sondermeyer P 1986 Complete characterization of the human IGF-I nucleotide sequence isolated from a newly constructed adult liver cDNA library. FEBS Lett 196:108-112 (Pubitemid 16048193)
15. Bebenek K, Kunkel TA 1989 The use of native T7 DNA polymerase for site-directed mutagenesis. Nucleic Acids Res 17:5408 (Pubitemid 19173388)
16. Forbes BE, Hartfield PJ, McNeil KA, Surinya KH, Milner SJ, Cosgrove LJ, Wallace JC 2002 Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur J Biochem 269:961-968
17. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Ward CW, Wallace JC 2004 Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol 18:2502-2512 (Pubitemid 39335984)
18. Buchou T, Charollais RH, Fagot D, Mester J 1989 Mitogenic activity of phorbol esters and insulin-like growth factor 1 in chemically transformed mouse fibroblasts BP-A31: independent effects and differential sensitivity to inhibition by 3-isobutyl-1-methyl xanthine. Exp Cell Res 182:129-143 (Pubitemid 19123460)
19. Sempé M, Pedron G, Roy-Penot M 1979 Auxologie, méthode et séquences. Paris: Théraplix
20. Usher R, McLean F 1969 Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 74:901-910
21. Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Le Bouc Y, Povoa G, Merimee TJ, Hossenlopp P, Binoux M 1989 Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 69:1291-1301 (Pubitemid 20010061)
22. Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A 1991 Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13-21
23. Heding A, Gill R, Ogawa Y, De Meyts P, Shymko RM 1996 Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J Biol Chem 271:13948-13952 (Pubitemid 26190283)
24. Denley A, Wang CC, McNeil KA, Walenkamp MJ, van Duyvenvoorde H, Wit JM, Wallace JC, Norton RS, Karperien M, Forbes BE 2005 Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. Mol Endocrinol 19:711-721 (Pubitemid 40349442)
25. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82 (Pubitemid 23306022)
26. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72 (Pubitemid 23306021)
27. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts- Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617 (Pubitemid 24021017)
28. D'Ercole AJ, Ye P, O'Kusky JR 2002 Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209-220 (Pubitemid 35041881)
29. Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ 2002 Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 22:6041-6051 (Pubitemid 35387647)
30. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ 2003 Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144:3799-3810 (Pubitemid 37088732)
31. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
32. Bayne ML, Applebaum J, Underwood D, Chicchi GG, Green BG, Hayes NS, Cascieri MA 1989 The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor. J Biol Chem 264:11004-11008 (Pubitemid 19168823)
33. Dubaquié Y, Lowman HB 1999 Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3. Biochemistry 38:6386-6396 (Pubitemid 129514936)
34. Moss JA, Francis GL, Ross M, Wallace JC, Ballard FJ 1991 Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein.An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction. J Biol Chem 266:909-914 (Pubitemid 21907202)
35. Cascieri MA, Chicchi GG, Applebaum J, Hayes NS, Green BG, Bayne ML 1988 Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor. Biochemistry 27:3229-3233 (Pubitemid 18132116)
36. Jansson M, Andersson G, Uhlén M, Nilsson B, Kördel J 1998 The insulin-like growth factor (IGF) binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis. J Biol Chem 273:24701-24707 (Pubitemid 28454970)
37. Zhang W, Gustafson TA, Rutter WJ, Johnson JD 1994 Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity. J BiolChem269:10609-10613 (Pubitemid 24198264)
38. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfäffle R, Raile K, Seidel B, Smith RJ, Chernausek SD 2003 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211-2222 (Pubitemid 37485137)
39. Savage MO, Camacho-Hübner C, David A, Metherell LA, Hwa V, Rosenfeld RG, Clark AJ 2007 Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy? Eur J Endocrinol 157(Suppl 1):S33-S37